The Food and Drug Administration has approved expanded use of Dysport to treat upper- and lower-limb spasticity – including that caused by cerebral palsy – for patients as young as 2 years and older, ...
The safety and efficacy of repeat injections of botulinum toxin A (BTX-A) into the upper limb of children with spastic hemiplegic cerebral palsy (CP) who are receiving occupational therapy has not yet ...
The FDA has approved the expanded use of Botox® (onabotulinumtoxinA; Allergan) for the treatment of spasticity in pediatric patients aged ≥2 years, including those with lower limb spasticity caused by ...
New York, NY--October 22, 2020--Cerebral palsy (CP) is the most common childhood physical disability--2.0-3.5 per 1000 births--and children born with it have impaired development and diminished ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback